PT 141 Nasal Spray at Dischem: What You Need to Know

Dis-Chem does not sell PT-141 nasal spray. Dis-Chem is a South African pharmacy chain, and no regulator — including the FDA in the United States and SAHPRA in South Africa — has approved a nasal spray version of PT-141 (bremelanotide). The only approved bremelanotide product in the US is Vyleesi, a subcutaneous injection for premenopausal women with hypoactive sexual desire disorder (HSDD).

If you landed here after seeing a marketplace listing or a social post, the rest of this article explains what PT-141 really is, how it is legally sold, and why a pharmacy chain cannot stock it in a spray bottle.

Does Dischem Sell PT 141 Nasal Spray?

No. Dis-Chem stocks medicines and supplements registered with the South African Health Products Regulatory Authority (SAHPRA), along with general pharmacy items. A nasal spray containing bremelanotide is not one of them, and there is no registered bremelanotide product in South Africa at all.

Dis-Chem pharmacists can answer questions about prescription and over-the-counter products, but they cannot sell a compounded or research-grade peptide as a consumer nasal spray. Any listing advertising a "Dis-Chem PT-141 spray" is describing a product that does not exist.

What Is PT-141 and What Is It Approved For?

PT-141 is the research name for bremelanotide, a synthetic peptide that activates melanocortin receptors in the brain. It was originally studied as a tanning agent before researchers noticed effects on sexual arousal.

The FDA approved Vyleesi in 2019 for acquired, generalized HSDD in premenopausal women. The labeled dose is 1.75 mg injected under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity, with no more than one dose in 24 hours and no more than eight doses per month.

Bremelanotide is not approved to treat erectile dysfunction in men. Trials in men showed modest results, and regulators did not clear it for that use. PT-141 is a prescription medicine rather than a supplement, and it is not a cure for any condition.

PT-141 Nasal Spray vs Injection

The practical difference comes down to approval, absorption, and predictability. Only the injection has been through the trials required for FDA approval, and nasal delivery has never been validated in a large human study.

People searching for pt-141 nasal spray vs injection are usually trying to avoid needles or spend less. Neither goal is served well by an unapproved spray, because the concentration, particle size, and preservatives are unverified, so each dose can deliver a different amount of drug.

PT 141 Nasal Spray Dosage and What the Evidence Shows

There is no official pt 141 nasal spray dosage, because no nasal product has ever been approved. Numbers circulating online — often 1 to 2 mg per nostril or a "10 mg/mL" mixture — come from forum posts and vendor pages, not from clinical labeling.

The only dose with regulatory backing is the injected one: 1.75 mg subcutaneously, once per 24 hours, up to eight times a month. Anything beyond that is guesswork. Reported side effects of bremelanotide include nausea, flushing, headache, and injection-site reactions, and the drug can raise blood pressure temporarily.

Repeated use can also cause darkening of the gums, skin, or nails, a side effect that is often hard to reverse. Anyone with uncontrolled high blood pressure or cardiovascular disease should speak with a clinician before considering bremelanotide at all.

How People Use It — and What to Watch For

Tutorials that explain how to use pt-141 nasal spray describe priming the pump, aiming at the outer nasal wall, and avoiding a hard sniff. Those techniques are borrowed from other nasal medicines and have not been tested with bremelanotide.

Key risks of buying a nasal spray pt-141 from a gray-market vendor include:

• No guarantee of peptide purity, sterility, or actual drug content
• Unlabeled preservatives that can irritate or damage nasal tissue
• Inconsistent dosing between bottles and batches
• No medical supervision if side effects appear

Vendor reviews are a poor guide. Positive pt-141 peptide nasal spray reviews are anecdotal, frequently incentivized, and rarely verified, and placebo responses are common with any product marketed for sexual arousal.

Recipes for making a nasal spray at home typically start with reconstituting lyophilized powder in bacteriostatic water. That process carries a real risk of contamination and dosing error, and it produces an unapproved drug that is illegal to sell for human use.

Legal Status and Safer Alternatives

In the United States, bremelanotide is a prescription-only medicine, so importing it without a prescription is not legal. In South Africa, unregistered medicines require a Section 21 authorization from SAHPRA, which a pharmacy counter sale cannot provide.

If you are dealing with low sexual desire, options that actually have evidence behind them include:

• A conversation with a physician or sexual-medicine specialist about diagnosis
• Approved treatments such as flibanserin or Vyleesi in the US
• Reviewing medications that can suppress libido, including SSRIs
• Addressing sleep, stress, and relationship factors, which often matter most

Dis-Chem pharmacists can point customers toward registered products and refer them to a prescriber, but they cannot supply a peptide nasal spray.

Bottom Line

PT-141 nasal spray is not sold at Dis-Chem, and it is not approved by the FDA, SAHPRA, or the European Medicines Agency. Bremelanotide is a prescription injection in the US, and every nasal version on the market is an unregulated research chemical sold with a "not for human consumption" label.

If you are considering PT-141 in any form, talk with a licensed healthcare professional first, and treat any online spray as unverified and potentially unsafe.